Related Experiment Video

Updated: Aug 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event--temporal trends]

Osana Maria Coelho Costa Mouco1, José Carlos Nicolau, Tatiana da Rocha E Souza

  • 1Hospital de Base da Faculdade, Instituto do Coração do Hospital das Clínicas, Faculdade de Medicina de São José do Rio Preto, FMUSP. ocoelho@cardiol.br

Arquivos Brasileiros De Cardiologia
|August 15, 2006
PubMed

Insights

Atherosclerotic plaque stabilization in acute coronary syndromes (ACS) may occur within three months, indicated by inflammatory markers like C-reactive protein (CRP) and factor VIIIc. Interleukin-6 (IL-6) also suggests stabilization by three months and predicts future cardiovascular events.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Biomarker Research

Context:

  • Acute coronary syndromes (ACS) involve plaque instability.
  • Understanding plaque stabilization is crucial for managing ACS.
  • Inflammatory markers are implicated in ACS pathogenesis.

Purpose:

  • To determine the timeline of atherosclerotic plaque stabilization in non-ST-segment elevation ACS (NSTE-ACS).
  • To evaluate the utility of inflammatory markers (CRP, fibrinogen, factor VIIIc, IL-6, TNF-alpha) in assessing plaque stabilization.
  • To identify inflammatory markers with prognostic value for future cardiovascular events.

Summary:

  • In NSTE-ACS patients, C-reactive protein (CRP) and factor VIIIc levels normalized by three months post-discharge, suggesting plaque stabilization.
  • Interleukin-6 (IL-6) levels decreased significantly between discharge and three months, indicating stabilization, but remained elevated for six months.
  • Only IL-6 demonstrated a significant independent correlation with future cardiovascular events within a year.

Impact:

  • Suggests plaque stabilization in ACS patients can be assessed within three months using specific inflammatory markers.
  • Highlights IL-6 as a key prognostic biomarker for cardiovascular events post-ACS.
  • Provides insights into the temporal dynamics of inflammation and plaque stability after ACS.
Abstract

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammation01:38

Inflammation

Overview
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...